Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,400,238 papers from all fields of science
Search
Sign In
Create Free Account
Committee, Drug
Known as:
Therapeutics Committee
, Committees, Formulary
, Pharmacy Committees
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Pharmacy and Therapeutics Committee
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Preliminary Safety and Efficacy Results from a Phase 2 Study of Acalabrutinib, Venetoclax and Obinutuzumab in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL).
B. Lampson
,
S. Tyekucheva
,
+13 authors
M. Davids
Blood
2019
Corpus ID: 208017941
DISCLOSURES Montegaard: Pharmacyclics: Consultancy; Janssen: Consultancy. Jacobson:Kite, a Gilead Company: Consultancy, Honoraria…
Expand
Review
2017
Review
2017
Development and Evaluation of a Human Single Chain Variable Fragment (scFv) Derived Bcma Targeted CAR T Cell Vector Leads to a High Objective Response Rate in Patients with Advanced MM
Eric L. Smith
,
S. Mailankody
,
+25 authors
R. Brentjens
2017
Corpus ID: 217189551
Patients with relapsed/refractory MM (RRMM) rarely obtain durable remissions with available therapies. Clinical use of BCMA…
Expand
2012
2012
[The Raman Spectroscopy (RS): A new tool for the analytical quality control of injectable in health settings. Comparison of RS technique versus HPLC and UV/Vis-FTIR, applied to anthracyclines as…
P. Bourget
,
A. Amin
,
A. Moriceau
,
B. Cassard
,
F. Vidal
,
R. Clément
Pathologie et biologie
2012
Corpus ID: 196169834
2012
2012
Rehabilitating opioid regulation: a prescription for the FDA's next proposal of an opioid risk evaluation and mitigation strategy (REMS).
Hilary N. Homenko
Health matrix (Cleveland, Ohio : )
2012
Corpus ID: 23781419
2009
2009
RNAI Therapeutics: A Two-Year Update
Jeffrey Perkel
2009
Corpus ID: 59110802
Two years is a long time in the world of RNAi therapeutics. Since Science last covered the topic in 2007, the first Phase 3 human…
Expand
2006
2006
RNAi therapeutics: SNALPing siRNAs in vivo
J. Rossi
Gene Therapy
2006
Corpus ID: 7232293
The novel use of a lipid bilayer system to get fusogenic delivery of siRNAs to murine liver cells to inhibit replication of the…
Expand
Review
2004
Review
2004
Ensuring preparedness for potential poliomyelitis outbreaks: Recommendations for the US poliovirus vaccine stockpile from the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on…
L. Alexander
,
G. Birkhead
,
+6 authors
T. Murphy
Archives of Pediatrics & Adolescent Medicine
2004
Corpus ID: 20479060
Paralytic poliomyelitis was once endemic in the United States; however, because of high vaccination levels, the last case of wild…
Expand
2001
2001
Comparison of baseline data, initial course, and management: losartan versus captopril following acute myocardial infarction (The OPTIMAAL Trial). OPTIMAAL Trial Steering Committee and Investigators…
K. Dickstein
,
J. Kjekshus
American Journal of Cardiology
2001
Corpus ID: 25391955
1997
1997
Inactivated poliovirus vaccine alone or sequential inactivated and oral poliovirus vaccine in two-, four- and six-month-old infants with combination Haemophilus influenzae type b/hepatitis B vaccine.
N. A. Halsey
,
M. Blatter
,
+7 authors
Carlton K. Meschievitz
The Pediatric Infectious Disease Journal
1997
Corpus ID: 5577388
BACKGROUND Advisory committees have recommended the increased use of inactivated poliovirus vaccine (IPV) for children…
Expand
Review
1979
Review
1979
Drug prescribing for the elderly in Saskatchewan during 1976.
S. L. Skoll
,
R. August
,
G. E. Johnson
Canadian Medical Association journal
1979
Corpus ID: 46254461
Over 11% of Saskatchewan's population is 65 years of age or older. To study patterns of prescribing for the elderly a computer…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE